Oceanside, CA, United States of America

Clinton E Browne


Average Co-Inventor Count = 3.2

ph-index = 10

Forward Citations = 574(Granted Patents)


Location History:

  • Escondido, CA (US) (1995)
  • Oceanside, CA (US) (1992 - 1997)
  • Gainesville, FL (US) (1997 - 1998)
  • Vista, CA (US) (1998 - 1999)

Company Filing History:


Years Active: 1992-1999

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Clinton E Browne: Innovator in Adenosine Research

Introduction

Clinton E Browne, based in Oceanside, California, is an accomplished inventor with a total of 12 patents to his name. His innovative contributions primarily focus on the field of biochemistry, specifically targeting adenosine function and its modulation in therapeutic contexts.

Latest Patents

Among his latest notable patents are those related to adenosine kinase inhibitors. These novel compounds selectively inhibit adenosine kinase, offering methods to prepare these inhibitors. They possess the potential to treat various conditions that can benefit from increased local concentrations of adenosine. Additionally, Browne has developed analogs of AICA riboside, which are useful in increasing extracellular levels of adenosine, furthering the understanding and application of adenosine in therapeutic scenarios.

Career Highlights

Clinton E Browne has had a significant impact in the pharmaceutical industry, particularly through his tenures at Gensia Pharmaceuticals, Inc. and Gensia, Inc. His work at these companies has contributed to advancements in drug development, especially in therapies targeting adenosine-related conditions.

Collaborations

Throughout his career, Browne has collaborated with notable professionals in the field, including Bheemarao G Ugarkar and Ronald R Tuttle. These collaborations have likely enriched the research environment, fostering innovation and leading to the successful development of key patents.

Conclusion

Clinton E Browne stands out as a significant figure in the field of adenosine research, driven by his commitment to innovation and discovery. His contributions to the development of adenosine kinase inhibitors and AICA riboside analogs reflect his dedication to furthering therapeutic options in medicine. Through his inventiveness, Browne continues to pave the way for new treatments that may improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…